|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.21 USD | -5.99% |
|
-3.70% | +0.28% |
| 07-17 | Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares | MT |
| 07-04 | Certain Common Stock of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.02B | - | - | - | - | - |
| 53.83B | |||||
| 52.1B | |||||
| 23.48B | - | ||||
| 23.13B | - | ||||
| 19.36B |
Select your edition
All financial news and data tailored to specific country editions
